Mucopolysaccharidosis IVA
6 clinical trials · Condition
◉ Watch Mucopolysaccharidosis IVA
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety Study of BMN 110 for Morquio A Syndrome Patients Who Have Limited Ambulation (NCT01697319) | BioMarin Pharmaceutical | 2012-08-01 |
| Safety and Exercise Study of Two Doses of BMN 110 for Morquio A Syndrome (NCT01609062) | BioMarin Pharmaceutical | 2012-04-01 |
| Study of BMN 110 in Pediatric Patients < 5 Years of Age With Mucopolysaccharidosis IVA (Morquio A Syndrome) (NCT01515956) | BioMarin Pharmaceutical | 2011-10-01 |
| A Study to Evaluate the Long-Term Efficacy and Safety of BMN 110 in Patients With Mucopolysaccharidosis IVA (Morquio A Syndrome) (NCT01242111) | BioMarin Pharmaceutical | 2010-11-01 |
| A Clinical Assessment Study of Subjects With Mucopolysaccharidosis IVA (Morquio Syndrome) (NCT00787995) | BioMarin Pharmaceutical | 2008-10-01 |
| BMN 110 US Expanded Access Program (NCT01858103) | BioMarin Pharmaceutical |
Track Mucopolysaccharidosis IVA automatically
Every clearance here is in the API, with alerts when new ones post.